<div id="readability-page-1"><p>Oppenheimer &amp; Co. Inc. purchased a new stake in  Hamilton Lane Inc. (NASDAQ:HLNE - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor  purchased 17,332 shares of the company's stock, valued at approximately $2,328,000.</p><div><p><span></span><span>Get <strong>Hamilton Lane</strong> alerts:</span></p></div><ul><li>Stock Rotation is Underway: Here are the Winners Moving Forward</li></ul><p>A number of other institutional investors and hedge funds also recently modified their holdings of HLNE. Millennium Management LLC increased its stake in shares of  Hamilton Lane by 418.8% in the 3rd quarter. Millennium Management LLC now owns 1,060,511 shares of the company's stock valued at $142,946,000 after acquiring an additional 856,112 shares during the last quarter.  Champlain Investment Partners LLC grew its position in shares of  Hamilton Lane by 33.8% in the 3rd quarter. Champlain Investment Partners LLC now owns 1,388,380 shares of the company's stock valued at $187,140,000 after purchasing an additional 350,437 shares during the period.  Vaughan Nelson Investment Management L.P. acquired a new position in shares of  Hamilton Lane in the 4th quarter valued at approximately $40,855,000.  Deprince Race &amp; Zollo Inc. acquired a new position in shares of  Hamilton Lane in the 4th quarter valued at approximately $40,480,000.  Finally, Massachusetts Financial Services Co. MA grew its position in shares of  Hamilton Lane by 6,649.0% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 286,699 shares of the company's stock valued at $38,507,000 after purchasing an additional 282,451 shares during the period. 97.40% of the stock is owned by institutional investors. </p><h2>Analyst Upgrades and Downgrades</h2><p>Several brokerages recently issued reports on HLNE. Oppenheimer decreased their price objective on Hamilton Lane from $230.00 to $171.00 and set an &#34;outperform&#34; rating for the company in a research report on Monday, April 13th. UBS Group decreased their price objective on Hamilton Lane from $184.00 to $150.00 and set a &#34;buy&#34; rating for the company in a research report on Friday, February 20th. Keefe, Bruyette &amp; Woods boosted their price objective on Hamilton Lane from $161.00 to $170.00 and gave the company an &#34;outperform&#34; rating in a research report on Thursday, January 8th. JPMorgan Chase &amp; Co. upgraded Hamilton Lane from a &#34;neutral&#34; rating to an &#34;overweight&#34; rating and set a $166.00 price objective for the company in a research report on Thursday, April 16th. Finally, Zacks Research lowered Hamilton Lane from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Monday, April 6th. Six equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $155.38.</p><p><b>Check Out Our Latest Analysis on Hamilton Lane</b></p><h2>Hamilton Lane Trading Down 1.6%</h2><p>NASDAQ:HLNE opened at $91.12 on Tuesday. Hamilton Lane Inc. has a twelve month low of $86.47 and a twelve month high of $179.19. The company has a quick ratio of 3.27, a current ratio of 3.27 and a debt-to-equity ratio of 0.21. The business has a 50 day moving average price of $100.31 and a two-hundred day moving average price of $120.63. The company has a market cap of $5.08 billion, a P/E ratio of 16.36 and a beta of 1.18. </p><p>Hamilton Lane (NASDAQ:HLNE - Get Free Report) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts' consensus estimates of $1.28 by $0.27. Hamilton Lane had a return on equity of 27.82% and a net margin of 30.59%.The firm had revenue of $198.59 million during the quarter, compared to the consensus estimate of $195.36 million. During the same quarter in the prior year, the firm posted $1.25 EPS. The business's revenue was up 18.0% on a year-over-year basis.  As a group, analysts expect that  Hamilton Lane Inc. will post 6.2 EPS for the current fiscal year. </p><h2>About Hamilton Lane</h2> (Free Report)<p>Hamilton Lane is a global private markets investment management firm specializing in the full spectrum of private equity and credit strategies. The company partners with institutional investors and wealth managers to design, implement and manage customized portfolios in primary fund investing, secondary market transactions and direct co-investment opportunities. By combining investment selection, portfolio construction and ongoing monitoring, Hamilton Lane seeks to optimize risk-adjusted returns across diverse private markets exposures.  </p><p>Founded in 1991, Hamilton Lane has developed a track record of investment and advisory services in private markets.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Hamilton Lane</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SExORQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SExORQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Hamilton Lane Right Now?</h2><p>Before you consider Hamilton Lane, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.</p><p>While Hamilton Lane currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

HLNE

<p>Oppenheimer & Co. Inc. has acquired a new stake in Hamilton Lane Inc. (NASDAQ:HLNE), purchasing 17,332 shares valued at approximately $2.33 million. Other institutional investors have also increased their holdings in Hamilton Lane. Analysts have issued mixed ratings, with Oppenheimer lowering its price target from $230 to $171, while JPMorgan upgraded the stock to 'overweight' with a target of $166. Hamilton Lane's stock is currently trading at $91.12, with a market cap of $5.08 billion and a P/E ratio of 16.36. The company reported strong earnings, exceeding estimates with a revenue increase of 18% year-over-year.</p>

Market Beat

Hamilton Lane 

Oppenheimer

UBS Group AG

JPMorgan Chase

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Oppenheimer & Co. Inc. Takes Position in Hamilton Lane Inc. $HLNE